Ufp Technologies SEC Filings

UFP Technologies Chief Financial Officer Ronald J. Lataille reported stock-based awards that increase his direct common stock holdings. On February 10, 2026, he acquired 2,463 shares at $0 per share upon achievement of performance targets under the 2003 Incentive Plan, bringing his direct holdings to 15,460 shares.

He also acquired 3,115 time-based stock unit awards to be settled solely in common shares at $0 per share, increasing his direct holdings reported to 18,575 shares. The performance-based units vest in three equal installments on March 1, 2026, 2027, and 2028, while the time-based awards vest in three equal installments on March 1, 2027, 2028, and 2029, subject to continued employment. In addition to these direct holdings, he also owns 38,940 shares of UFP Technologies, Inc. indirectly.

UFP Technologies CEO R. Jeffrey Bailly reported equity awards of common stock on February 10, 2026. He acquired 7,428 restricted stock units tied to 2025 performance goals and 19,061 time-based stock units granted under the company’s 2003 Incentive Plan, all to be settled in common shares.

Following these grants, Bailly directly held 179,585 shares of common stock. A footnote also notes an additional 28,706 shares held indirectly by a trust, with beneficial ownership disclaimed except for any pecuniary interest.

Wasatch Advisors filed an amended Schedule 13G showing a significant ownership position in UFP Technologies, Inc. common stock. Wasatch reports beneficial ownership of 782,708 shares, representing 10.1% of the outstanding class as of the event date.

The firm has sole voting power over 537,721 shares and sole dispositive power over all 782,708 shares, with no shared voting or dispositive power. Wasatch certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of UFP Technologies.

UFP Technologies (UFPT) reported insider activity by a senior vice president. On 11/06/2025, the officer sold a total of 1,829 shares of common stock in multiple trades, with weighted-average sale prices across tranches ranging from $219.82 to $232.29. Following these sales, the reporting person directly owned 10,756 shares.

UFP Technologies (UFPT) reported steady Q3 performance with strong year‑to‑date momentum. Net sales were $154.6 million versus $145.2 million a year ago, and net income was $16.4 million compared with $16.4 million. For the first nine months, sales rose to $453.9 million from $360.4 million, with net income up to $50.7 million from $42.6 million as recent acquisitions contributed meaningfully.

Gross profit increased in Q3 to $42.7 million, though operating income softened to $23.4 million. Diluted EPS was $2.11 in Q3 and $6.52 year‑to‑date. Operating cash flow strengthened to $75.1 million for the nine months, supporting lower borrowings under the credit facilities. Total debt was $146.1 million at quarter‑end, and cash was $18.2 million. Medical end‑markets comprised 92.1% of Q3 sales, reflecting the company’s focus on single‑use medical devices.

UFPT continued integrating acquisitions. In 2025 it acquired Techno Plastics Industries for $4.5 million and Universal Plastics & Engineering Company for $7.5 million. 2024 acquisitions included AJR Enterprises ($110.0 million), Welch Fluorocarbon ($34.6 million), AQF (€43 million), and Marble Medical ($4.5 million). Customer concentration remained notable, with two customers accounting for 27.1% and 17.1% of Q3 sales.

UFP Technologies (UFPT) reported that it issued a press release announcing financial results for the third quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1 to this Form 8-K.

The company states that the information under Item 2.02, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act. The release includes forward-looking statements and a related cautionary note. UFPT’s common stock trades on The NASDAQ Stock Market L.L.C. under the symbol UFPT.

Daniel C. Croteau, a director of UFP Technologies, Inc. (UFPT), reported two open-market sales of common stock on 09/05/2025. The first sale reports 1,000 shares sold at $206.045 with 2,728 shares beneficially owned after that transaction. The second sale reports 1,873 shares sold at $206.00 with 855 shares beneficially owned after that transaction. The Form 4 was signed by an attorney-in-fact on 09/08/2025.

Form 144 notice for UFP Technologies Inc. (UFPT) shows a proposed sale of 2,873 shares of common stock through UBS Financial Services with an aggregate market value of $591,883. The shares represent part of the company's listed outstanding shares of 7,711,126 and the proposed approximate sale date is 09/05/2025 on NASDAQ.

The filing discloses the acquisition history for the shares to be sold: 1,318 shares were acquired by exercising options on 08/07/2025 (paid in cash), and the remainder came from vesting of stock unit awards on 05/31/2022 (610 shares), 05/31/2023 (647 shares), and 05/31/2024 (298 shares) with the awards treated as compensation. The filer reports no sales of issuer securities in the past three months.

UFP Technologies, Inc. filed a Form 8-K to furnish updated investor presentation materials under Regulation FD. The company attached the revised presentation as Exhibit 99.1, which it plans to use in meetings with investors, other interested parties, and in various speaking engagements. The materials are designated as furnished, not filed, meaning they are not subject to certain Exchange Act liabilities or automatically incorporated into other SEC filings. The company also notes that the presentation includes forward-looking statements and directs readers to the cautionary language in the slides regarding risks and uncertainties that could cause actual results to differ.